K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species

Background/Objectives: With mucocutaneous candidiasis being highly prevalent in HIV patients, the emergence of fluconazole-resistant Candida species forms a major challenge in treating and eradicating these infections. The objective of this study was to establish the antifungal activity of K21, a me...

Descripción completa

Detalles Bibliográficos
Autores principales: John, Cathy N., Abrantes, Pedro M. D. S., Prusty, Bhupesh K., Ablashi, Dharam V., Africa, Charlene W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558409/
https://www.ncbi.nlm.nih.gov/pubmed/31231313
http://dx.doi.org/10.3389/fmicb.2019.01021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558409/
https://www.ncbi.nlm.nih.gov/pubmed/31231313
http://dx.doi.org/10.3389/fmicb.2019.01021

Ejemplares similares